---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "uovMSMHR2SPyNITJG+vW8Vcjp4iViy9j/Zo2j4SMq192SbSJbqz94G/72klyDEeOxhz+5wI6iyRZMZeigRKkbkikZGDEizCi/tvlpHFO36Znp4yG97scmDnMvqlVmAqQQ1jKQSkdMW2WrWVLv4xwBAmb++4qsQXC7gFqq54iXPPiemBQhsW+i0sRmWR9CCyMcJ9HaHvJfdtcJXhgevVbugiz7pzv8VzkABKG6lT9u+0KZh+umQ8tN3Cfy9UOAWegrUbifUCspQ53VYFyTazYGt+VRUA4O1e2Tkmeh9N+PuzIC1dTPxag07nl9I2kdJLf;muf/3y9Ufgh7z0MceA0vYg=="
---

